On August 14, 2023, DiaMedica Therapeutics Inc. closed the transaction. The company issued 11,000,000 shares at a price of $3.4 per shares for gross proceeds of $37.4 million. The transaction included participation from accredited investors, including several members of the company's management team.

After deducting estimated offering expenses, the company received net proceeds of approximately $36.1 million.